SCHEMBL5437607

SCHEMBL5437607

O=c1[nH]c(=O)n(-c2ccccc2)c2nc(Cl)c(-c3ccccc3)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 2/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
DHFR P00374 6/20 0.44
PDE5A O76074 1/20 0.44
PDE1A P54750 1/20 0.44
PDE1B Q01064 1/20 0.44
PDE3B Q13370 1/20 0.44
PDE1C Q14123 1/20 0.44
PDE3A Q14432 1/20 0.44
MAPT P10636 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
XDH P47989 1/20 0.40
PKM P14618 1/20 0.40
LMNA P02545 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5434692 0.85 KDM4E (0.56) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6314968 0.84 DHFR (0.46) KDM4EALDH1A1GAAHPGDDHFR
SCHEMBL5435684 0.81 PNP (0.53) KDM4EALDH1A1GAAHPGDPDE5A
SCHEMBL5443072 0.80 MEN1 (0.45) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL5434638 0.75 MEN1 (0.47) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL5434556 0.74 ALDH1A1 (0.44) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL6320759 0.73 KDM4E (0.48) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL5454885 0.73 BRDT (0.44) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL24182595 0.72 ALDH1A1 (0.56) KDM4EALDH1A1GLAGAAHPGD
SCHEMBL30670160 0.71 MAT2A (0.45) KDM4EALDH1A1GAAHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-20070043000-A1 Immunosuppresive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2007-02-22 US disclosed
EP-1636232-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA Bioscience nv (BE) 2006-03-22 EP disclosed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
WO-2004104005-A2 IMMUNOSUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES 4 AZA BIOSCIENCE NV (BE) 2004-12-02 WO disclosed
EP-1479682-A1 Immunosuppressive effects of pteridine derivatives 4 AZA Bioscience nv (BE) 2004-11-24 EP disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043000-A1 Immunosuppresive effects of pteridine derivatives TPMT, FKBP5, RRP15 KDM4E 1686/4885ALDH1A1 1767/4885GLA 3872/4885
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 KDM4E 1278/4885ALDH1A1 1744/4885GLA 3863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.